ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,794.77
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Nighthawk Biosciences Inc (NHWK)

  7. Nighthawk Biosciences Inc (NHWK) News

Nighthawk Biosciences (NHWK)

Nighthawk Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NHWK
DateTimeSourceHeadlineSymbolCompany
03/05/202421:00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NHWKNighthawk Biosciences Inc
03/05/202412:18Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:NHWKNighthawk Biosciences Inc
02/05/202413:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
30/04/202413:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
29/04/202413:10Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
22/04/202422:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/04/202421:52Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:NHWKNighthawk Biosciences Inc
19/03/202412:30GlobeNewswire Inc.Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major UniversityAMEX:NHWKNighthawk Biosciences Inc
14/03/202412:30GlobeNewswire Inc.Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-ConsortiumAMEX:NHWKNighthawk Biosciences Inc
13/03/202410:17Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]AMEX:NHWKNighthawk Biosciences Inc
13/03/202410:01Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
12/03/202421:00GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Closing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
08/03/202405:20GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Pricing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
07/03/202421:18GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Proposed Public Offering of Common StockAMEX:NHWKNighthawk Biosciences Inc
07/03/202413:30GlobeNewswire Inc.Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023AMEX:NHWKNighthawk Biosciences Inc
06/02/202414:34Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
06/02/202413:00GlobeNewswire Inc.NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open TodayAMEX:NHWKNighthawk Biosciences Inc
01/02/202413:00GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating OfficerAMEX:NHWKNighthawk Biosciences Inc
30/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
30/01/202413:00GlobeNewswire Inc.NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing NoteAMEX:NHWKNighthawk Biosciences Inc
26/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
25/01/202413:30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical ProgramAMEX:NHWKNighthawk Biosciences Inc
22/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
16/01/202413:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
16/01/202413:30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New ClientAMEX:NHWKNighthawk Biosciences Inc
11/01/202421:59Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
08/01/202413:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
08/01/202413:30GlobeNewswire Inc.NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMOAMEX:NHWKNighthawk Biosciences Inc
03/01/202413:30GlobeNewswire Inc.NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National UniversityAMEX:NHWKNighthawk Biosciences Inc
27/12/202321:57Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
 Showing the most relevant articles for your search:AMEX:NHWK

Your Recent History

COIN
WIZEUR
NYSE
AEO
American Eagle Outfitters
NASDAQ
JOAN
JOANN
LSE
FOGL
LSE
AA4
Amedeo Air Four Plus
LSE
BLP
Blue Planet Investment
USOTC
HSHPF
Hill and Smith (PK)
BIT
F18982
Vontobel Financial Produ...
LSE
MGCI
M&g Credit Income Invest...
LSE
OXS
Oxus Gold
NYSE
TAP.A
Molson Coors Beverage
EU
MDM
Maisons du Monde
LSE
75SB
Vodafone 37
EU
XS0677080599
Bank Voor Netherlands Ge...
BTHB
XRPKRW
Ripple
NASDAQ
SALE
RETAILMENOT, INC.
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved